bridging hepatic fibrosis

bridging hepatic fibrosis

area of liver fibrosis that bridges adjacent portal areas to central veins due to excess deposition of collagen determined by microscopic review of liver tissue sample.
References in periodicals archive ?
This NIH-funded study randomised patients with HCV infection and advanced fibrosis (bridging hepatic fibrosis or cirrhosis) to receive long-term maintenance therapy with a low dose of PEGIFNa or to remain untreated for a period of 4 years.